Biotech Startups Turn To Big Pharma For Survival

Worcester Business Journal -- Money for startup biotechs sure is hard to come by in this economy. And that means more companies are being forced to consider being acquired in order to survive and bring their products to market.

MORE ON THIS TOPIC